Day: August 4, 2011

Qui tam troll attacks Allergan

After paying $600 million to settle off-label marketing claims, Allergan agreed to drop its First Amendment challenges to the FDA’s off-label promotion rules.  Now Allergan

READ MORE
Subscribe

Email Address*